参考文献/References:
1 中华医学会.临床技术操作规范放射肿瘤分册.北京:人民军医出版社,2005.117-118.
2 陈名,蒋国梁,朱国培.放射肿瘤学临床前瞻性随机试验的设计和实施.见:蒋国梁.现代肿瘤放射治疗学.上海:上海科技出版社,2003.673.
3 Turrisi AT. A case against surgery for most Ⅲa non small cell lung cancer. Semin Oncol, 2005, 32(2 Suppl 3):S6-8.
4 朱广迎,祝淑钗,吕长兴,等.肺癌.见:朱广迎.放射肿瘤学(笫二版).北京:科学技术文献出版社,2007.325-326.
5 Gandara DR, Chansky K, Albain KS, et al. Long-term survival with concurrent chemoradlation therapy followed by consolidation docetaxel in stage ⅢB non-small-cell lung cancer:a phase Ⅱ Southwest Oncology Group Study (S9504). Clin Lung Cancer, 2006, 8(2):116-121.
6 Heelan RT, Hilaris BS, Anderson LL, et al. Lung tumors:percutaneous implantation of I-125 sources with CT treatment planning. J Radiology. 1987, 164(3):735-740.
7 Valentin J, Low-dose extrapolation of radlation-related cancer risk. Ann ICRP, 2005, 35(4):1-140.
8 Ye SJ, Brezovich IA, Shen S, et al. Dose errors due to inhomogeneities in balloon catheter brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys, 2004, 60(2):672-677.
9 Siebert FA, Kohr P, Kovacs G.Comparison of CT-and radiographbased post-implant doslmetry for transperineal 125I prostate brachytherapy using single seeds and a commercial treatment-planning software. Strahlenther Onkol, 2006, 182(2):96-101.
10 Taussky D, Yeung I, Williams T, et al.Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy. Int J Radiat Oncol Biol Phys, 2006, 65(2):358-363.
11 中华医学会.临床诊疗指南肿瘤分册.北京:人民卫生出版社,2005:117-118.
12 Li DF, Cui Q, Wang Q, et al. Application of I(125) brachytherapy combined artificial joint prosthesis in malignant osteo-and soft-tissue sarcoma. Cancer Biother Radiopharm. 2006. 21(2):167-172.
相似文献/References:
[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[3]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[4]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[5]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[6]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[7]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[8]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[9]邓艳,张伟.125I-碘酞酸盐临床应用进展[J].国际放射医学核医学杂志,2016,40(3):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
Deng Yan,Zhang Wei.125I-iothalamate clinical applications[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
[10]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[11]汤敏敏,刘建中,武志芳,等.分化型甲状腺癌患者131I治疗后体内残留放射性活度的评估[J].国际放射医学核医学杂志,2014,38(6):363.[doi:10.3760/cma.j.issn.1673-4114.2014.06.004]
Tang Min-min,Liu Jian-zhong,Wu Zhi-fang,et al.Estimation of residual activities in patients with differentiated thyroid cancer after administration of 131I for therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):363.[doi:10.3760/cma.j.issn.1673-4114.2014.06.004]
[12]胡丽丽,李小东,张雪宁,等.影像引导下125I粒子植入治疗肺癌的疗效分析[J].国际放射医学核医学杂志,2013,37(4):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
HU Li-li,LI Xiao-dong,ZHANG Xue-ning,et al.Efficacy of CT guided radioactive 125I seed implantation in the treatment of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):203.[doi:10.3760/cma.j.issn.1673-4114.2013.04.004]
[13]朱晓珉,方文岩,陈军,等.CT导向下125I粒子植入治疗难治生肺癌的疗效观察[J].国际放射医学核医学杂志,2011,35(2):114.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
ZHU Xiao-min,FANG Wen-yan,CHEN Jun,et al.CT guided interstitial 125I seed implantation treatment of refractory lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):114.[doi:10.3760/cma.j.issn.1673-4114.2011.02.012]
[14]梁吉祥,柴树德,郑广钧,等.CT引导下植入125I粒子治疗非小细胞肺癌切除术后局部复发的疗效[J].国际放射医学核医学杂志,2011,35(3):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
LIANG Ji-xiang,CHAI Shu-de,ZHENG Guang-jun,et al.CT-guided percutaneous interstitial implantation of 125I for recurrent patients of postoperative non-small cell lung carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(6):181.[doi:10.3760/cma.j.issn.1673-4114.2011.03.012]
[15]孔维静,徐颖.综合干预措施下评估首次131I清甲治疗对分化型甲状腺癌患者唾液腺的慢性损伤[J].国际放射医学核医学杂志,2018,(1):30.[doi:10.3760/cma.j.issn.1673-4114.2018.01.006]
Kong Weijing,Xu Ying.Assessment of the chronic injury of salivary glands in patients with differentiated thyroid cancer who underwent comprehensive intervention measures with first 131I clearing therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(6):30.[doi:10.3760/cma.j.issn.1673-4114.2018.01.006]
[16]南楠,朱小华.分化型甲状腺癌131I显像假阳性的原因分析[J].国际放射医学核医学杂志,2018,(1):62.[doi:10.3760/cma.j.issn.1673-4114.2018.01.012]
Nan Nan,Zhu Xiaohua.Analysis of the false positive findings on 131I whole-body scan in differentiated thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(6):62.[doi:10.3760/cma.j.issn.1673-4114.2018.01.012]
[17]王任飞,田小丽,谭建,等.腰椎能谱CT评估Graves甲状腺功能亢进症患者131I治疗前后骨量变化的价值[J].国际放射医学核医学杂志,2018,(6):495.[doi:10.3760/cma.j.issn.1673-4114.2018.06.004]
Wang Renfei,Tian Xiaoli,Tan Jian,et al.Changes of bone mass in patients with Graves’ hyperthyroidism before and after 131I therapy based on CT spectral imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2018,(6):495.[doi:10.3760/cma.j.issn.1673-4114.2018.06.004]